Nam Da Eun, Park Jin Hee, Park Cho Eun, Jung Na Young, Nam Soo Hyun, Kwon Hye Mi, Kim Hyun Su, Kim Sang Beom, Son Won Seok, Choi Byung-Ok, Chung Ki Wha
Department of Biological Sciences, Kongju National University, Gongju, South Korea.
Department of Health Sciences and Technology, SAIHST, Sungkyunkwan University, Seoul, South Korea.
J Peripher Nerv Syst. 2022 Mar;27(1):38-49. doi: 10.1111/jns.12476. Epub 2021 Dec 1.
Charcot-Marie-Tooth disease (CMT) and related diseases are a genetically and clinically heterogeneous group of peripheral neuropathies. Particularly, mutations in several aminoacyl-tRNA synthetase (ARS) genes have been reported to cause axonal CMT (CMT2) or distal hereditary motor neuropathy (dHMN). However, the common pathogenesis among CMT subtypes by different ARS gene defects is not well understood. This study was performed to investigate ARS gene mutations in a CMT cohort of 710 Korean families. Whole-exome sequencing was applied to 710 CMT patients who were negative for PMP22 duplication. We identified 12 disease-causing variants (from 13 families) in GARS1, AARS1, HARS1, WARS1, and YARS1 genes. Seven variants were determined to be novel. The frequency of overall ARS gene mutations was 1.22% among all independent patients diagnosed with CMT and 1.83% in patients negative for PMP22 duplication. WARS1 mutations have been reported to cause dHMN; however, in our patients with WARS1 variants, CMT was associated with sensory involvement. We analyzed genotype-phenotype correlations and expanded the phenotypic spectrum of patients with CMT possessing ARS gene variants. We also characterized clinical phenotypes according to ARS genes. This study will be useful for performing exact molecular and clinical diagnoses and providing reference data for other population studies.
夏科-马里-图斯病(CMT)及相关疾病是一组在遗传和临床方面具有异质性的周围神经病变。特别是,据报道,几种氨酰-tRNA合成酶(ARS)基因突变会导致轴索性CMT(CMT2)或远端遗传性运动神经病(dHMN)。然而,不同ARS基因缺陷导致的CMT亚型之间的共同发病机制尚未完全明确。本研究旨在调查710个韩裔家庭的CMT队列中的ARS基因突变情况。对710例PMP22基因重复检测为阴性的CMT患者进行了全外显子测序。我们在GARS1、AARS1、HARS1、WARS1和YARS1基因中鉴定出12个致病变异(来自13个家庭)。其中7个变异被确定为新发现的变异。在所有确诊为CMT的独立患者中,ARS基因突变的总体频率为1.22%,在PMP22基因重复检测为阴性的患者中为1.83%。据报道,WARS1基因突变会导致dHMN;然而,在我们患有WARS1变异的患者中,CMT与感觉受累有关。我们分析了基因型-表型相关性,扩展了具有ARS基因变异的CMT患者的表型谱。我们还根据ARS基因对临床表型进行了特征描述。本研究将有助于进行准确的分子和临床诊断,并为其他人群研究提供参考数据。